Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder

Nandeesha, Hanumanthappa, Keshri, Neha, Rajappa, Medha, Menon, Vikas · 2023 · Archives of Physiology and Biochemistry

Abstract

The objective of the study was to investigate the association of blood glucose and lipid profile parameters with cognitive impairment in schizophrenia. A total of 200 schizophrenia patients and 169 controls were enrolled in the study. Blood glucose and lipid profile were estimated in all the subjects. Cognition was assessed using Addenbrooke cognitive examination-III (ACE-III). Fasting glucose (p ≤ .001) and triacylglycerol (p = .018) were increased and HDL-Cholesterol (p ≤ .001), was reduced in schizophrenia. Glucose (r = −0.158, p = .026), total cholesterol (r = −0.249, p = .0001) and triacylglycerol (r = −0.168, p = .018) was negatively correlated with total ACE III score. Triacylglycerol (p = .041) was elevated in cases with mild cognitive impairment. Plasma glucose, total cholesterol and triacylglycerol were associated with various cognitive domains suggesting that hyperglycaemia and hyperlipidaemia might increase the risk of cognitive impairment in schizophrenia.

Overview

Integrity signals

Registry

Crossref · 10.1080/13813455.2020.1839500

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 3

  1. 10.3109/10401230109148955 · doi:10.3109/10401230109148955
  2. Jimenez, M.A. and Guerrero, J.L.G., 2017. Disorders associated with mild cognitive impairment. Risk factors and predictors. Revista espanola de geriatria y gerontologia, 52, 20–23.
  3. Krug, A. and Kircher, T., 2017. Cognitive disorders in schizophrenia. Fortschritte der neurologie-psychiatrie, 85 (5), 292–304.

Cited by

See all 20

Metadata

Authors
Nandeesha, H., Keshri, N., Rajappa, M., & Menon, V.
Affiliations
Jawaharlal Institute of Post Graduate Medical Education and Research (IN)
Corresponding author
Nandeesha, Hanumanthappa
Venue
Archives of Physiology and Biochemistry
Published
2020-11-03
Volume
129
Issue
2
Pages
497-504
ISSN
  • 0778-3124 (ISSN-L)
  • 1381-3455
  • 1744-4160
OpenAlex
W3095213654
Cited by
17
References
32
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 1
FWCI
1.28
Type
journal article
Language
en
Open access
closed
Licence
doi.org/10.1080/policies-text-data-mining (tdm)
Locations
  • Archives of Physiology and Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
JIPMER
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
schizophrenia, cognitive impairment, hyperglycemia, hyperlipidemia, fasting blood glucose, lipid profile, triglycerides, total cholesterol, HDL cholesterol, mild cognitive impairment, schizophrenia spectrum disorders
MeSH terms
Blood Glucose, Glucose, Humans, Hyperglycemia, Hyperlipidemias, Cholesterol, HDL, Schizophrenia, Triglycerides, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder. https://app.cochat.ai/papers/10.1080/13813455.2020.1839500
The paper
Nandeesha, H., Keshri, N., Rajappa, M., & Menon, V. (2023). Association of hyperglycaemia and hyperlipidaemia with cognitive dysfunction in schizophrenia spectrum disorder. Archives of Physiology and Biochemistry. https://doi.org/10.1080/13813455.2020.1839500

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.